Qing Song Health Co.,Ltd. (TPE:6931)
70.10
-0.80 (-1.13%)
At close: Mar 18, 2025
Qing Song Health Revenue
Qing Song Health had revenue of 282.39 million TWD in the quarter ending June 30, 2025, with 15.27% growth. This brings the company's revenue in the last twelve months to 1.05 billion, up 12.78% year-over-year. In the year 2024, Qing Song Health had annual revenue of 982.56 million with 13.11% growth.
Revenue (ttm)
1.05B
Revenue Growth
+12.78%
P/S Ratio
3.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 982.56M | 113.90M | 13.11% |
Dec 31, 2023 | 868.66M | 231.98M | 36.43% |
Dec 31, 2022 | 636.69M | 279.15M | 78.08% |
Dec 31, 2021 | 357.54M | 117.30M | 48.83% |
Dec 31, 2020 | 240.24M | 115.74M | 92.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
PharmaEssentia | 12.63B |
Pegavision | 6.67B |
Sunmax Biotechnology | 1.95B |
Center Laboratories | 1.60B |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |